Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

105.85 +51.22 (+93.76%)
Streaming Delayed Price Updated: 2:12 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,900,081
Open 94.93
Bid (Size) 105.73 (2)
Ask (Size) 106.12 (2)
Prev. Close 54.63
Today's Range 87.58 - 106.36
52wk Range 22.00 - 75.00
Shares Outstanding 115,926,629
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
These stocks are gapping in today's session
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill

Performance

YTD
+111.8%
+111.8%
1 Month
+74.7%
+74.7%
3 Month
+108.2%
+108.2%
6 Month
+128.7%
+128.7%
1 Year
+311.2%
+311.2%

More News

Read More
Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Mr. Cooper Group, Southern States Bancshares, Corcept Therapeutics And Other Big Stocks Moving Higher On Monday
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Exploring NASDAQ:CORT's high growth characteristics.
Via Chartmill
Monday's pre-market session: top gainers and losers
Via Chartmill
Nasdaq Tumbles Over 300 Points; Chicago PMI Rises In March
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
From Corcept Therapeutics Incorporated
Via Business Wire
3 Reasons to Sell CORT and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
Exposures US Equities
CORCEPT THERAPEUTICS INC (NASDAQ:CORT), a growth stock which is not overvalued.
Via Chartmill
3 Growth Stocks in Hot Water
Via StockStory
1 Small-Cap Stock on Our Buy List and 2 to Avoid
Via StockStory
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
From Corcept Therapeutics Incorporated
Via Business Wire
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
FDA Files Corcept’s New Drug Application for Relacorilant as Treatment for Patients With Hypercortisolism
From Corcept Therapeutics Incorporated
Via Business Wire
Why Corcept (CORT) Shares Are Sliding Today
Via StockStory
Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q4 Earnings
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2024 Audited Financial Results and Provides Corporate Update
From Corcept Therapeutics
Via Business Wire
While growth is established for NASDAQ:CORT, the stock's valuation remains reasonable.
Via Chartmill
Corcept (CORT) Q4 Earnings Report Preview: What To Look For
Via StockStory
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results, Provide Corporate Update and Host Conference Call
From Corcept Therapeutics Incorporated
Via Business Wire
Looking for growth without the hefty price tag? Consider NASDAQ:CORT.
Via Chartmill

Frequently Asked Questions

Is Corcept Therapeutics Incorporated - Common Stock publicly traded?
Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.
What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?
Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?
The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market
What is the current price of Corcept Therapeutics Incorporated - Common Stock?
The current price of Corcept Therapeutics Incorporated - Common Stock is 105.85
When was Corcept Therapeutics Incorporated - Common Stock last traded?
The last trade of Corcept Therapeutics Incorporated - Common Stock was at 03/31/25 02:12 PM ET
What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?
The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 12.27B
How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?
Corcept Therapeutics Incorporated - Common Stock has 12B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.